Parallel functional and immunological detection of human multidrug resistance proteins, P-glycoprotein and MRP1

被引:0
|
作者
Holló, Z [1 ]
Homolya, L [1 ]
Hegedûs, T [1 ]
Müller, M [1 ]
Szakács, G [1 ]
Jakab, K [1 ]
Antal, F [1 ]
Sarkadi, B [1 ]
机构
[1] Hungarian Acad Sci, Natl Inst Haematol & Immunol, Membrane Res Grp, H-1113 Budapest, Hungary
关键词
multiple drug resistance; P-glycoprotein; multidrug resistance-associated protein; ABC transporters; fluorometry; digital imaging; neoplasms; immunofluorescence; calcein;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The proper assessment of the expression and drug extrusion activity of multidrug resistance proteins in various tumor cells is a challenging clinical laboratory problem. Recently, we have introduced a fluorescent dye (calcein) accumulation assay for the estimation of the functional expression of both P-glycoprotein (MDR1) and the multidrug resistance-associated protein (MRP1). Since both MDR1 and MRP1 decrease the intracellular accumulation of the fluorescent free calcein, by applying appropriate inhibitors of MDR1 and MRP1, the transport activity of these proteins could be quantitatively and selectively estimated in fluorometry or flow-cytometry assays. In the present work single-cell fluorescence digital imaging has been applied to characterize the kinetics and inhibitor-sensitivity of calcein accumulation in a mixture of HL60 MRP1 and NIH 3T3 MDR1 cells. Subsequent immunofluorescence labeling was performed by the anti-MDR1 monoclonal antibody (mAb) UIC2 in the same cell population. We report that the double labeling approach, based on the single cell calcein accumulation assay and an immunofluorescence detection, provides good sensitivity and selectivity for the simultaneous functional and immunological detection of cellular MDR1 and MRP1.
引用
收藏
页码:2981 / 2987
页数:7
相关论文
共 50 条
  • [41] P-GLYCOPROTEIN IN HUMAN SARCOMA - EVIDENCE FOR MULTIDRUG RESISTANCE
    GERLACH, JH
    BELL, DR
    KARAKOUSIS, C
    SLOCUM, HK
    KARTNER, N
    RUSTUM, YM
    LING, V
    BAKER, RM
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (09) : 1452 - 1460
  • [42] Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia. A Southwest Oncology Group Study
    Leith, CP
    Kopecky, KJ
    Chen, IM
    Eijdems, L
    Slovak, ML
    McConnell, TS
    Head, DR
    Weick, J
    Grever, MR
    Appelbaum, FR
    Willman, CL
    BLOOD, 1999, 94 (03) : 1086 - 1099
  • [43] The use of Tris-Lipidation to modify drug cytotoxicity in multidrug resistant cells expressing P-glycoprotein or MRP1
    Davey, RA
    Davey, MW
    Cullen, KV
    Wells, XE
    Francis, CL
    Williams, HM
    Yang, Q
    Moghaddam, MJ
    Widmer, F
    Whittaker, RG
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 137 (08) : 1280 - 1286
  • [44] Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2
    Keppler, D
    Leier, I
    Jedlitschky, G
    BIOLOGICAL CHEMISTRY, 1997, 378 (08) : 787 - 791
  • [45] Identification and characterization of human multidrug resistance protein 1 (MRP1) mutations
    Conrad, S
    Kauffmann, HM
    Ito, K
    Leslie, EM
    Deeley, RG
    Cole, SPC
    Schrenk, D
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R161 - R161
  • [46] Oleanolic acid inhibits the activity of the multidrug resistance protein ABCC1 (MRP1) but not of the ABCB1 (P-glycoprotein): Possible use in cancer chemotherapy
    Braga, F.
    Ayres-Saraiva, D.
    Gattass, C. R.
    Capella, M. A. M.
    CANCER LETTERS, 2007, 248 (01) : 147 - 152
  • [47] MULTIDRUG RESISTANCE DUE TO P-GLYCOPROTEIN
    BURT, RK
    FOJO, AT
    THORGEIRSSON, SS
    HOSPITAL PRACTICE, 1990, 25 (04): : 67 - &
  • [49] Structure of the multidrug resistance P-glycoprotein
    Higgins, CF
    Callaghan, R
    Linton, KJ
    Rosenberg, MF
    Ford, RC
    SEMINARS IN CANCER BIOLOGY, 1997, 8 (03) : 135 - 142
  • [50] P-glycoprotein multidrug resistance and cancer
    Bosch, I
    Croop, J
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1288 (02): : F37 - F54